4 completed, 3 active not recruiting, 1 terminated, 1 unknown. 9 Phase 2, 3 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 4, Active not recruiting 3, Terminated 1, Unknown 1 |
| Phase 1 | 3 | Completed 2, Active not recruiting 1 |
| Phase 3 | 1 | Unknown 1 |
Follow type1diabetes: new trials by email Literature Review of type1diabetes trials Research Report on type1diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes Pramlintide, Lyumjev, Automated Insulin Delivery (AID) system - type1diabetes, Diabetes Mellitus, Type 1 | Phase 2 / Phase 3 | Unknown | McGill University Health Centre/Research Institute of the McGill University Health Centre | 30 | 2023-11-30 | 2024-04-18 |
| Butyrate Adjuvant Therapy for Type 1 Diabetes BKR-017 - Type1diabetes | Phase 1 / Phase 2 | Completed | Mayo Clinic | 6 | 2022-07-28 | 2026-03-31 |
| Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents the ATMP Protrans - Type1diabetes | Phase 1 / Phase 2 | Active not recruiting | Uppsala University Hospital | 66 | 2022-01-14 | 2026-04-28 |
| A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes YG1699, Dapagliflozin - Diabetes, Diabetes Mellitus, Type 1 | Phase 2 | Completed | Youngene Therapeutics Inc., Ltd. | 19 | 2021-06-17 | 2022-07-28 |
| Reducing Innate Inflammation in New Onset Type 1 Diabetes Lactiplantibacillus plantarum, Placebo - Type 1 Diabetes, type1diabetes | Phase 2 | Active not recruiting | Medical College of Wisconsin | 51 | 2021-04-01 | 2026-10-20 |
| IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase Regular insulin (Humulin-R), intranasal route, SipNose intranasal device - Type1diabetes | Phase 2 | Terminated | HealthPartners Institute | 4 | 2019-10-23 | 2021-05-18 |
| Evaluation of Coffee Therapy for Improvement of Renal Oxygenation Starbucks® Cold brew - 325ml bottle - Type1diabetes, Type1 Diabetes Mellitus | Phase 2 | Completed | University of Colorado, Denver | 10 | 2019-07-01 | 2022-02-15 |
| Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes ProTrans, Control - Type1diabetes | Phase 1 / Phase 2 | Completed | NextCell Pharma Ab | 15 | 2019-05-17 | 2025-03-07 |
| Probiotics in Newly Diagnosed T1D Visbiome, Placebo - Type 1 Diabetes, Type1diabetes | Phase 2 | Active not recruiting | Medical College of Wisconsin | 43 | 2019-04-01 | 2026-11-02 |
Diabetes Mellitus, Type 1 (6) · Diabetes Mellitus (2) · Diabetes Complications (1) · Diabetic Nephropathies (1) · Insulin Resistance (1)
Autoimmune Diseases (6) · Endocrine System Diseases (6) · Glucose Metabolism Disorders (6) · Immune System Diseases (6) · Metabolic Diseases (6) · Nutritional and Metabolic Diseases (6) · Diabetes Mellitus (4) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Hyperinsulinism (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Butyrates (1) · Drug Delivery Systems (1) · Insemination, Artificial, Heterologous (1) · Insulin (1) · Transplantation, Homologous (1) · dapagliflozin (1) · pramlintide (1)
Medical College of Wisconsin (2) · HealthPartners Institute (1) · Mayo Clinic (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · NextCell Pharma Ab (1) · University of Colorado, Denver (1) · Uppsala University Hospital (1) · Youngene Therapeutics Inc., Ltd. (1)
United States (6) · Sweden (2) · Canada (1)
Adrian Vella, MD (1) · Ahmad Haidar, Ph.D. (1) · Anders L Carlson, MD (1) · Laurent Legault, M.D. (1) · Melissa-Rosina Pasqua, M.D. (1) · Michael Tsoukas, M.D. (1) · Michael Vallis, Ph.D. (1) · Natasha Garfield, M.D. (1) · Per-Ola Carlsson, MD, PhD (1) · Per-Ola Carlsson, PhD (1) · Petter Bjornstad, MD (1)
2018 (1)